Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Climb Bio (NASDAQ:CLYM) through any online brokerage.
There are no as such competitors for Climb Bio.
Climb Bio has a consensus price target of $20.15.
The stock price for Climb Bio (NASDAQ: CLYM) is $10.71 last updated June 16, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Climb Bio.
Climb Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Climb Bio.
Climb Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.